Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: A VALUE substudy

Journal of Hypertension

Volumn 25, Issue 3, 2007, Pages 707-712

  Pedersen, Ole Lederballe ^a   Mancia, Giuseppe ^b   Pickering, Thomas ^c   Høegholm, Asbjørn ^d   Julius, Stevo ^e   Kjeldsen, Sverre E ^e,f   Nielsen, Eric S ^a   Refsgaard, Jens ^a   Weber, Michael ^g  

^a VIBORG HOSPITAL   (Denmark)

^b SAN GERARDO HOSPITAL   (Italy)

^c New York Presbyterian Hospital Columbia University Medical Center   (United States)

^d NAESTVED HOSPITAL   (Denmark)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF OSLO   (Norway)

^g SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Ambulatory blood pressure; Amlodipine; Hypertension; Valsartan; VALUE trial

Indexed keywords

AMLODIPINE; VALSARTAN;

AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE;

EID: 33846811367     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3280147119     Document Type: Article

References (17)

1. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al., for the VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial. Lancet 2004; 363:2022-2031.
2. Svensson P, de Faire U, Sleight P, Yusuf S, Östergren J. Comparative effects of ramipril on ambulatory and office blood pressures. Hypertension 2001; 38:e28-e32.
3. Kjeldsen SE, Julius S, Brunner HR, Hansson L, Henis M, Ekman S, et al., for the VALUE Trial Group. Characteristics of 15314 hypertensive patients at high coronary risk. The VALUE trial. Blood Press 2001; 10:83-91.
4. Palatini P, Mugellini A, Spagnuolo V, Santonastaso M, Ambrosia GB, Caiazza A, Malacco E, Investigators Group. Comparison of the effects on 24-h ambulatory blood pressure of valsartan and amlodipine, alone or in combination with a low-dose diuretic, in elderly patients with isolated systolic hypertension (Val-syst Study). Blood Press Monit 2004; 9:91-97.
5. Eguchi K, Kario K, Hoshide Y, Hoshide S, Ishikawa J, Morinari M, et al. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients. Am J Hypertens 2004; 17:112-117.
6. Julius S, Kjeldsen SE, Brunner H, Hansson L, Platt F, Ekman S, et al., for the VALUE Trial. VALUE Trial: Long-term BP trends in 13449 patients with hypertension at high cardiovascular risk. Am J Hypertens 2003; 16:544-548.
7. de Champlain J, Karas M, Nguyen P, Carter P, Vistaff R, Toal C, et al. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens 1998; 16:1357-1369.
8. Karas M, Lacourcie' re Y, LeBlanc A-R, Nadeau R, Dube B, Florescu M, et al. Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients. J Hypertens 2005; 23:1251-1260.
9. Pedersen O, Refsgaard J, Nielsen ES. Heart rate variability and ECG changes in 148 Danish patients after two years in the VALUE trial [abstract]. Am J Hypertens 2005; 18 (suppl 1):A91.
10. Palatini P. Non-dipping in hypertension: still a challenging problem. J Hypertens 2004; 22:2269-2272.
11. Ohkubo T, Hozava A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20:2183-2189.
12. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 2003; 42:283-290.
13. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW. Predicting cardiovascular risk using conventional versus ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282:539-546.
14. Mancia G, Omboni S, Parati G, on behalf of the Investigators of the INSIGHT ABPM substudy. Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT). J Hypertens 2002; 20:545-553.
15. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure and mortality. A population based study. Hypertension 2005; 45:499-504.
16. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriosi Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111:1777-1783.
17. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality. The Dublin outcome study. Hypertension 2005; 46:156-161.